Loading...
XJPX
4120
Market cap25mUSD
Jul 10, Last price  
3,185.00JPY
1D
-1.39%
1Q
41.43%
Jan 2017
130.80%
Name

Sugai Chemical Industry Co Ltd

Chart & Performance

D1W1MN
XJPX:4120 chart
P/E
9.02
P/S
0.65
EPS
353.00
Div Yield, %
2.17%
Shrs. gr., 5y
-0.93%
Rev. gr., 5y
1.38%
Revenues
6.43b
-2.86%
5,700,722,0005,021,671,0005,316,619,0005,503,306,0005,521,594,0006,008,081,0006,232,914,0007,059,466,0007,617,230,0006,622,426,0006,432,802,000
Net income
461m
+27.00%
-124,609,000-10,464,000106,974,000230,632,000154,784,000317,903,000404,468,000578,931,000489,105,000363,122,000461,147,000
CFO
1.70b
+2,264.16%
237,217,0001,018,964,000959,366,0001,116,110,000-111,042,000245,248,0001,441,516,000931,904,0001,190,538,00071,851,0001,698,676,000
Dividend
Mar 30, 202670 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sugai Chemical Industry Co., Ltd. is a Japanese enterprise specializing in the production and distribution of a wide array of chemical products. The company supplies pharmaceutical intermediates vital for the creation of medicines targeting conditions such as circulatory, respiratory, and central nervous system disorders, as well as antimicrobial, antiviral, and anti-cancer treatments. Its product line also encompasses active ingredients and intermediates for agrochemicals like fungicides, insecticides, and herbicides, in addition to veterinary pharmaceuticals. Furthermore, Sugai Chemical provides functional chemicals utilized in optical and electronic materials, resins and monomers, cosmetics, and fragrances. Other offerings include intermediaries for dyes and pigments, alongside various surfactants. Founded in 1928, the company changed its name from Sugai Chemical Factory to its present form in 1952. Its corporate headquarters are situated in Wakayama, Japan.
IPO date
Feb 01, 1963
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT